enGene Holdings Inc. Quarterly Income Tax Expense (Benefit) in USD from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
enGene Holdings Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2022 to Q2 2024.
  • enGene Holdings Inc. Income Tax Expense (Benefit) for the quarter ending July 31, 2024 was -$29K.
  • enGene Holdings Inc. Income Tax Expense (Benefit) for the twelve months ending July 31, 2024 was -$21K.
  • enGene Holdings Inc. annual Income Tax Expense (Benefit) for 2023 was $17K, a 22.7% decline from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$21K -$29K -$29K May 1, 2024 Jul 31, 2024 10-Q 2024-09-10
Q1 2024 $8K $21K +$21K Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 -$13K -$30K -$30K Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 $17K $17K Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 $0 May 1, 2023 Jul 31, 2023 10-Q 2024-09-10
Q1 2023 $0 Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $0 Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.